New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer
- 21 December 2007
- journal article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 15 (3), 140-153
- https://doi.org/10.1038/sj.cgt.7701118
Abstract
Persistent infection by high-risk types of human papillomaviruses (HPV) is a necessary cause of cervical cancer, with HPV16 the most prevalent, accounting for more than 50% of reported cases. The virus encodes the E6 and E7 oncoproteins, whose expression is essential for maintenance of the malignant phenotype. To select efficacious siRNAs applicable to RNAi therapy for patients with HPV16+ cervical cancer, E6 and E7 siRNAs were designed using siDirect computer software, after which 10 compatible with all HPV16 variants were selected, and then extensively examined for RNAi activity and specificity using HPV16+ and HPV16−cells. Three siRNAs with the highest RNAi activities toward E6 and E7 expression, as well as specific and potent growth suppression of HPV16+ cancer cells as low as 1 nM were chosen. Growth suppression was accompanied by accumulation of p53 and p21WAF1/CIP1, as well as morphological and cytochemical changes characteristic of cellular senescence. Antitumor activity of one of the selected siRNAs was confirmed by retarded tumor growth of HPV16+ cells in NOD/SCID mice when locally injected in a complex with atelocollagen. Our results demonstrate that these E6 and E7 siRNAs are promising therapeutic agents for treatment of virus-related cancer.Keywords
This publication has 54 references indexed in Scilit:
- RNA Interference against Human Papillomavirus Oncogenes in Cervical Cancer Cells Results in Increased Sensitivity to CisplatinMolecular Pharmacology, 2005
- Human Papillomavirus Oncoprotein E7 Targets the Promyelocytic Leukemia Protein and Circumvents Cellular Senescence via the Rb and p53 Tumor Suppressor PathwaysMolecular and Cellular Biology, 2005
- Mechanisms of Human Papillomavirus-Induced OncogenesisJournal of Virology, 2004
- Pathogenesis of Human Papillomaviruses in Differentiating EpitheliaMicrobiology and Molecular Biology Reviews, 2004
- siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cellsOncogene, 2003
- RNA Interference of Human Papillomavirus Type 18 E6 and E7 Induces Senescence in HeLa CellsJournal of Virology, 2003
- Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interferenceOncogene, 2002
- Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systemsProceedings of the National Academy of Sciences, 2001
- Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature, 2001
- Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: anti-proliferative effects on HPV 16-transformed cellsNucleic Acids Research, 1999